Tech Company Financing Transactions
Igenica Funding Round
Third Rock Ventures and private investors participated in a $2.3 million funding round for Igenica. The financing round was recorded on 3/31/2016.
Transaction Overview
Company Name
Announced On
3/31/2016
Transaction Type
Venture Equity
Amount
$2,250,000
Round
Undisclosed
Investors
Third Rock Ventures (Mark Goldsmith)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
863 Mitten Rd. 102
Burlingame, CA 94010
USA
Burlingame, CA 94010
USA
Phone
Website
Email Address
Overview
Igenica is a biopharmaceutical company developing antibody-based therapeutics for the treatment of cancer.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Financial Officer
Hans van Houte
VP - Bus. Development
John Celebi
Browse more venture capital transactions:
Prev: 3/31/2016: Kareo venture capital transaction
Next: 3/31/2016: IrisVR venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs